Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma.

Barlin JN, Mahar B, Ata A, Cormier B, Michelin D, Salani R, Backes F, Levinson K, Cantrell LA, Weinberg L, Wagreich A, Savage D, Gasson C, Denniston K, Martin J, McElrath T, Timmins PF

Open source

DOI: 10.1016/j.ygyno.2023.11.012
Published: 2024 Jan
Container: Gynecologic oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ygyno.2023.11.012,
  title = {Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma.},
  author = {Barlin JN and Mahar B and Ata A and Cormier B and Michelin D and Salani R and Backes F and Levinson K and Cantrell LA and Weinberg L and Wagreich A and Savage D and Gasson C and Denniston K and Martin J and McElrath T and Timmins PF},
  year = {2024},
  journal = {Gynecologic oncology},
  doi = {10.1016/j.ygyno.2023.11.012},
  url = {https://doi.org/10.1016/j.ygyno.2023.11.012}
}

RIS

TY  - JOUR
TI  - Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma.
AU  - Barlin JN
AU  - Mahar B
AU  - Ata A
AU  - Cormier B
AU  - Michelin D
AU  - Salani R
AU  - Backes F
AU  - Levinson K
AU  - Cantrell LA
AU  - Weinberg L
AU  - Wagreich A
AU  - Savage D
AU  - Gasson C
AU  - Denniston K
AU  - Martin J
AU  - McElrath T
AU  - Timmins PF
PY  - 2024
JO  - Gynecologic oncology
DO  - 10.1016/j.ygyno.2023.11.012
UR  - https://doi.org/10.1016/j.ygyno.2023.11.012
ER  -

APA

JN, B., B, M., A, A., B, C., D, M., R, S., F, B., K, L., LA, C., L, W., A, W., D, S., C, G., K, D., J, M., T, M., & PF, T. (2024). Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma.. Gynecologic oncology. https://doi.org/10.1016/j.ygyno.2023.11.012

Source records

pubmed · retrieved 2026-09-26T10:13:05.762Z